Fund HoldingsAquilo Capital Management, LLC

Total Portfolio Value
$58.39M
Total Bought
$19.59M
Total Sold
$66.53M
Net Transaction
-$46.94M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
AMGEN INC(AMGN)(Call)025,000+25,00006,516+6,516
PROTAGONIST THERAPEUTICS INC076,592+76,59202,9565.06%+2,956
ARROWHEAD PHARMACEUTICALS IN(ARWR)(Call)075,000+75,00001,410+1,410
BLUEPRINT MEDICINES CORP124,600129,600+5,00011,52611,30419.36%-222
BICYCLE THERAPEUTICS PLC181,911221,911+40,0004,1173,1075.32%-1,010
IMMATICS N.V(IMTX)333,502373,902+40,4003,8052,6584.55%-1,147
ADICET BIO INC2,531,1942,531,19403,6452,4354.17%-1,210
PRECISION BIOSCIENCES INC381,803536,376+154,5733,4212,0443.50%-1,377
REPARE THERAPEUTICS INC989,3641,293,715+304,3513,4031,6952.90%-1,709
ARROWHEAD PHARMACEUTICALS IN(ARWR)795,813707,589-88,22415,41513,30322.78%-2,112
KYMERA THERAPEUTICS INC(KYMR)208,743183,521-25,2229,8807,38312.64%-2,497
SUTRO BIOPHARMA INC762,498498-762,0002,63810.00%-2,637
SILENCE THERAPEUTICS PLC317,214367,214+50,0005,7672,5264.33%-3,241
ARVINAS INC388,766328,766-60,0009,5756,30210.79%-3,273
MERUS N V117,8550-117,8555,8880-5,888
REGENXBIO INC930,708346,302-584,4069,7632,6774.58%-7,086
SPDR S&P 500 ETF TR(SPY)(Put)75,0000-75,00043,0320-43,032
Page 1 of 1